My Bibliography - NCBI

My Bibliography - NCBI
Skip to main page content
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The
ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Access keys
NCBI Homepage
MyNCBI Homepage
Main Content
Main Navigation
MyNCBI
selected
select all 81
clear all
81 citations,
Sort by
newest to oldest
recently updated
newest to oldest
oldest to newest
author
author
select
Kramarenko GC, Gomez Casas C, Dang MN, Demetriou ND, Day ES.
Loading Density Influences the Tumor Cell Targeting and Signaling Inhibition Capabilities of Antibody Nanoconjugates.
ACS Omega
2026 Feb 10;
11
(5)
:8836-8847
doi: 10.1021/acsomega.5c13065.
eCollection 2026 Feb 10.
PubMed PMID:
41696244
; PubMed Central PMCID:
PMC12903012
select
Sterin EH, Kramarenko GC, Roy Chowdhury C, Tendulkar SP, Li K, Chaya T, Muscat-Rivera J, Melamed JR, Day ES.
Exogenous CD55 Expression on Membrane-Wrapped Nanoparticles Unexpectedly Increases Spleen Tropism and Immune Cell Uptake In Vivo.
ACS Nano Med
2026 Feb 11;
(1)
:283-296
doi: 10.1021/acsnanomed.5c00059.
eCollection 2026 Feb 11.
PubMed PMID:
41695019
; PubMed Central PMCID:
PMC12904091
select
Sterin EH, Weinstein LA, Tiwari A, Kramarenko GC, Chowdhury CR, Li K, Day ES.
Influence of the protein corona on hematopoietic stem and progenitor cell uptake and macrophage clearance of membrane-wrapped nanoparticles.
Proc Natl Acad Sci U S A
2025 Oct 7;
122
(40)
:e2507922122
doi: 10.1073/pnas.2507922122.
Epub 2025 Sep 29.
PubMed PMID:
41021803
; PubMed Central PMCID:
PMC12519180
select
Aboeleneen SB, Azevedo GM, Li K, Wolverton AM, Scully MA, Kramarenko GC, Day ES.
Cancer Cell Membrane-Wrapped Nanoparticles for Photothermal Therapy and Photoacoustic Imaging of Triple-Negative Breast Cancer.
ACS Appl Nano Mater
2025 Sep 5;
(35)
:17311-17328
doi: 10.1021/acsanm.5c03543.
eCollection 2025 Sep 5.
PubMed PMID:
40933950
; PubMed Central PMCID:
PMC12418301
select
Roy Chowdhury C, Hoover EC, Day ES.
Membrane-modified lipid nanoparticles for RNA delivery.
Mol Ther Methods Clin Dev
2025 Sep 11;
33
(3)
:101505
doi: 10.1016/j.omtm.2025.101505.
eCollection 2025 Sep 11.
Review.
PubMed PMID:
40612625
; PubMed Central PMCID:
PMC12221644
select
Sterin EH, Weinstein LA, Roy Chowdhury C, Guzzetti EC, Day ES.
Standard purification methods are not sufficient to remove micellular lipophilic dye from polymer nanoparticle solution.
RSC Pharm
2025 May 20;
(3)
:527-534
doi: 10.1039/d5pm00013k.
eCollection 2025 May 20.
PubMed PMID:
40083440
; PubMed Central PMCID:
PMC11895857
select
Hoover EC, Day ES.
Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem-Like Behavior in Triple-Negative Breast Cancer Cells.
J Biomed Mater Res A
2025 Jan;
113
(1)
:e37867
doi: 10.1002/jbm.a.37867.
PubMed PMID:
39760151
; PubMed Central PMCID:
PMC11800355
select
Hoover EC, Roy Chowdhury C, Ruggiero OM, Day ES.
Conjugation of Antibodies and siRNA Duplexes to Polymer Nanoparticles via Maleimide-Thiol Chemistry.
ACS Omega
2024 Dec 3;
(48)
:47637-47646
doi: 10.1021/acsomega.4c07025.
eCollection 2024 Dec 3.
PubMed PMID:
39651074
; PubMed Central PMCID:
PMC11618400
select
Dang MN, Suri S, Li K, Casas CG, Stigliano G, Riley RS, Scully MA, Hoover EC, Aboeleneen SB, Kramarenko GC, Day ES.
Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast Cancer.
Adv Ther (Weinh)
2024 Jun;
(6)
doi: 10.1002/adtp.202300426.
Epub 2024 Apr 26.
PubMed PMID:
39006318
; PubMed Central PMCID:
PMC11238604
select
Hoover EC, Ruggiero OM, Swingler RN, Day ES.
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer.
ACS Omega
2024 Mar 26;
(12)
:14323-14335
doi: 10.1021/acsomega.3c10275.
eCollection 2024 Mar 26.
PubMed PMID:
38559981
; PubMed Central PMCID:
PMC10976388
select
Scully MA, Wilhelm R, Wilkins DE, Day ES.
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer.
ACS Biomater Sci Eng
2024 Mar 11;
10
(3)
:1355-1363
doi: 10.1021/acsbiomaterials.4c00160.
Epub 2024 Feb 2.
PubMed PMID:
38306303
; PubMed Central PMCID:
PMC10939768
select
Sahni M, Day ES.
Nanotechnologies for the detection and treatment of endometriosis.
Front Biomater Sci
2023;
doi: 10.3389/fbiom.2023.1279358.
Epub 2023 Nov 16.
PubMed PMID:
38994324
; PubMed Central PMCID:
PMC11238427
select
Aboeleneen SB, Scully MA, Kramarenko GC, Day ES.
Combination cancer imaging and phototherapy mediated by membrane-wrapped nanoparticles.
Int J Hyperthermia
2023;
40
(1)
:2272066
doi: 10.1080/02656736.2023.2272066.
Epub 2023 Oct 30.
Review.
PubMed PMID:
37903544
; PubMed Central PMCID:
PMC10698846
select
Scully MA, Wilkins DE, Dang MN, Hoover EC, Aboeleneen SB, Day ES.
Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer.
Mol Pharm
2023 Aug 7;
20
(8)
:3895-3913
doi: 10.1021/acs.molpharmaceut.3c00009.
Epub 2023 Jul 17.
PubMed PMID:
37459272
; PubMed Central PMCID:
PMC10628893
select
Irvin-Choy NS, Nelson KM, Gleghorn JP, Day ES.
Delivery and short-term maternal and fetal safety of vaginally administered PEG-PLGA nanoparticles.
Drug Deliv Transl Res
2023 Dec;
13
(12)
:3003-3013
doi: 10.1007/s13346-023-01369-w.
Epub 2023 Jun 26.
PubMed PMID:
37365402
; PubMed Central PMCID:
PMC10913101
select
Fereshteh Z, Dang MN, Wenck C, Day ES, Slater JH.
E-Selectin Targeted Gold Nanoshells to Inhibit Breast Cancer Cell Binding to Lung Endothelial Cells.
ACS Appl Nano Mater
2023 Jan 27;
(2)
:1315-1324
doi: 10.1021/acsanm.2c04967.
Epub 2023 Jan 9.
PubMed PMID:
37789828
; PubMed Central PMCID:
PMC10544796
select
Das S, Harris JC, Winter EJ, Kao CY, Day ES, Papoutsakis ET.
Megakaryocyte membrane-wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells.
Bioeng Transl Med
2023 May;
(3)
:e10456
doi: 10.1002/btm2.10456.
eCollection 2023 May.
PubMed PMID:
37206243
; PubMed Central PMCID:
PMC10189472
select
Harris JC, Sterin EH, Day ES.
Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia.
ACS Biomater Sci Eng
2022 Oct 10;
(10)
:4439-4448
doi: 10.1021/acsbiomaterials.2c00832.
Epub 2022 Sep 14.
PubMed PMID:
36103274
; PubMed Central PMCID:
PMC9633094
select
Aboeleneen SB, Scully MA, Harris JC, Sterin EH, Day ES.
Membrane-wrapped nanoparticles for photothermal cancer therapy.
Nano Converg
2022 Aug 12;
(1)
:37
doi: 10.1186/s40580-022-00328-4.
Review.
PubMed PMID:
35960404
; PubMed Central PMCID:
PMC9373884
select
Scully MA, Sterin EH, Day ES.
Membrane-wrapped nanoparticles for nucleic acid delivery.
Biomater Sci
2022 Aug 9;
10
(16)
:4378-4391
doi: 10.1039/d2bm00447j.
Review.
PubMed PMID:
35796319
; PubMed Central PMCID:
PMC9486671
select
Iqbal S, Luo B, Melamed JR, Day ES.
Critical Evaluation of Different Lysosomal Labeling Methods Used to Analyze RNA Nanocarrier Trafficking in Cells.
Bioconjug Chem
2021 Oct 20;
32
(10)
:2245-2256
doi: 10.1021/acs.bioconjchem.1c00405.
Epub 2021 Sep 20.
PubMed PMID:
34543006
; PubMed Central PMCID:
PMC9014481
select
Irvin-Choy NS, Nelson KM, Dang MN, Gleghorn JP, Day ES.
Gold nanoparticle biodistribution in pregnant mice following intravenous administration varies with gestational age.
Nanomedicine
2021 Aug;
36
:102412
doi: 10.1016/j.nano.2021.102412.
Epub 2021 Jun 17.
PubMed PMID:
34147664
; PubMed Central PMCID:
PMC8641294
select
Dang MN, Hoover EC, Scully MA, Sterin EH, Day ES.
Antibody Nanocarriers for Cancer Management.
Curr Opin Biomed Eng
2021 Sep;
19
doi: 10.1016/j.cobme.2021.100295.
Epub 2021 May 26.
PubMed PMID:
34423177
; PubMed Central PMCID:
PMC8373047
select
Powsner EH, Harris JC, Day ES.
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies.
Advanced nanobiomed research.
2021 February
select
Dang MN, Gomez Casas C, Day ES.
Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells.
Nano Lett
2021 Jan 13;
21
(1)
:68-76
doi: 10.1021/acs.nanolett.0c03152.
Epub 2020 Dec 11.
PubMed PMID:
33306406
; PubMed Central PMCID:
PMC7855941
select
Nelson KM, Irvin-Choy N, Hoffman MK, Gleghorn JP, Day ES.
Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies.
Adv Drug Deliv Rev
2021 Mar;
170
:425-438
doi: 10.1016/j.addr.2020.09.013.
Epub 2020 Sep 28.
Review.
PubMed PMID:
33002575
; PubMed Central PMCID:
PMC7981251
select
Valcourt DM, Day ES.
Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers.
Mol Ther Nucleic Acids
2020 Sep 4;
21
:290-298
doi: 10.1016/j.omtn.2020.06.003.
Epub 2020 Jun 9.
PubMed PMID:
32622330
; PubMed Central PMCID:
PMC7332498
select
Irvin-Choy NS, Nelson KM, Gleghorn JP, Day ES.
Design of nanomaterials for applications in maternal/fetal medicine.
J Mater Chem B
2020 Aug 21;
(31)
:6548-6561
doi: 10.1039/d0tb00612b.
Epub 2020 May 26.
Review.
PubMed PMID:
32452510
; PubMed Central PMCID:
PMC7429305
select
Valcourt DM, Kapadia CH, Scully MA, Dang MN, Day ES.
Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines.
Adv Healthc Mater
2020 Jun;
(12)
:e2000110
doi: 10.1002/adhm.202000110.
Epub 2020 May 4.
Review.
PubMed PMID:
32367687
; PubMed Central PMCID:
PMC7473451
select
Wang J, Dang MN, Day ES.
Inhibition of Wnt signaling by Frizzled7 antibody-coated nanoshells sensitizes triple-negative breast cancer cells to the autophagy regulator chloroquine.
Nano Res
2020 Jun;
13
(6)
:1693-1703
doi: 10.1007/s12274-020-2795-8.
Epub 2020 Apr 25.
PubMed PMID:
33304449
; PubMed Central PMCID:
PMC7723362
select
Valcourt DM, Dang MN, Scully MA, Day ES.
Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.
ACS Nano
2020 Mar 24;
14
(3)
:3378-3388
doi: 10.1021/acsnano.9b09263.
Epub 2020 Feb 26.
PubMed PMID:
32083466
; PubMed Central PMCID:
PMC7098846
select
Wang J, Potocny AM, Rosenthal J, Day ES.
Gold Nanoshell-Linear Tetrapyrrole Conjugates for Near Infrared-Activated Dual Photodynamic and Photothermal Therapies.
ACS Omega
2020 Jan 14;
(1)
:926-940
doi: 10.1021/acsomega.9b04150.
eCollection 2020 Jan 14.
PubMed PMID:
31956847
; PubMed Central PMCID:
PMC6964518
select
Kapadia CH, Ioele SA, Day ES.
Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells.
J Biomed Mater Res A
2020 Mar;
108
(3)
:601-613
doi: 10.1002/jbm.a.36840.
Epub 2019 Nov 26.
PubMed PMID:
31742868
; PubMed Central PMCID:
PMC7103458
select
Harris JC, Scully MA, Day ES.
Cancer Cell Membrane-Coated Nanoparticles for Cancer Management.
Cancers (Basel)
2019 Nov 21;
11
(12)
doi: 10.3390/cancers11121836.
Review.
PubMed PMID:
31766360
; PubMed Central PMCID:
PMC6966582
select
Kapadia CH, Luo B, Dang MN, Irvin-Choy N, Valcourt DM, Day ES.
Polymer nanocarriers for MicroRNA delivery.
J Appl Polym Sci
2020 Jul 5;
137
(25)
doi: 10.1002/app.48651.
Epub 2019 Nov 12.
PubMed PMID:
33384460
; PubMed Central PMCID:
PMC7773200
select
Valcourt DM, Dang MN, Wang J, Day ES.
Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer.
Ann Biomed Eng
2020 Jul;
48
(7)
:1864-1884
doi: 10.1007/s10439-019-02399-7.
Epub 2019 Nov 4.
Review.
PubMed PMID:
31686312
; PubMed Central PMCID:
PMC7196499
select
Valcourt DM, Dang MN, Day ES.
IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer.
J Biomed Mater Res A
2019 Aug;
107
(8)
:1702-1712
doi: 10.1002/jbm.a.36685.
Epub 2019 Apr 9.
PubMed PMID:
30920169
; PubMed Central PMCID:
PMC7153575
select
Riley RS, Melamed JR, Day ES.
Enzyme-Linked Immunosorbent Assay to Quantify Targeting Molecules on Nanoparticles.
Methods Mol Biol
2018;
1831
:145-157
doi: 10.1007/978-1-4939-8661-3_11.
PubMed PMID:
30051430
select
Melamed JR, Ioele SA, Hannum AJ, Ullman VM, Day ES.
Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.
Mol Pharm
2018 Nov 5;
15
(11)
:5135-5145
doi: 10.1021/acs.molpharmaceut.8b00707.
Epub 2018 Oct 11.
PubMed PMID:
30260647
; PubMed Central PMCID:
PMC6469355
select
Riley RS, O'Sullivan RK, Potocny AM, Rosenthal J, Day ES.
Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells.
Nanomaterials (Basel)
2018 Aug 25;
(9)
doi: 10.3390/nano8090658.
PubMed PMID:
30149630
; PubMed Central PMCID:
PMC6164691
select
Potocny AM, Riley RS, O'Sullivan RK, Day ES, Rosenthal J.
Photochemotherapeutic Properties of a Linear Tetrapyrrole Palladium(II) Complex displaying an Exceptionally High Phototoxicity Index.
Inorg Chem
2018 Sep 4;
57
(17)
:10608-10615
doi: 10.1021/acs.inorgchem.8b01225.
Epub 2018 Aug 22.
PubMed PMID:
30132325
; PubMed Central PMCID:
PMC6167929
select
Kapadia CH, Melamed JR, Day ES.
Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.
BioDrugs
2018 Aug;
32
(4)
:297-309
doi: 10.1007/s40259-018-0290-5.
Review.
PubMed PMID:
29959665
; PubMed Central PMCID:
PMC6428072
select
Goyal R, Kapadia CH, Melamed JR, Riley RS, Day ES.
Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a.
Cell Mol Bioeng
2018 Oct;
11
(5)
:383-396
doi: 10.1007/s12195-018-0535-x.
Epub 2018 Jun 6.
PubMed PMID:
30555597
; PubMed Central PMCID:
PMC6289203
select
Melamed JR, Morgan JT, Ioele SA, Gleghorn JP, Sims-Mourtada J, Day ES.
Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide.
Oncotarget
2018 Jun 5;
(43)
:27000-27015
doi: 10.18632/oncotarget.25467.
eCollection 2018 Jun 5.
PubMed PMID:
29930746
; PubMed Central PMCID:
PMC6007474
select
Melamed JR, Kreuzberger NL, Goyal R, Day ES.
Spherical Nucleic Acid Architecture Can Improve the Efficacy of Polycation-Mediated siRNA Delivery.
Mol Ther Nucleic Acids
2018 Sep 7;
12
:207-219
doi: 10.1016/j.omtn.2018.05.008.
Epub 2018 Jun 2.
PubMed PMID:
30195760
; PubMed Central PMCID:
PMC6023847
select
Valcourt DM, Harris J, Riley RS, Dang M, Wang J, Day ES.
Advances in targeted nanotherapeutics: From bioconjugation to biomimicry.
Nano Res
2018 Oct;
11
(10)
:4999-5016
doi: 10.1007/s12274-018-2083-z.
Epub 2018 May 17.
PubMed PMID:
31772723
; PubMed Central PMCID:
PMC6879063
select
Riley RS, Dang MN, Billingsley MM, Abraham B, Gundlach L, Day ES.
Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation.
Nano Lett
2018 Jun 13;
18
(6)
:3565-3570
doi: 10.1021/acs.nanolett.8b00681.
Epub 2018 May 2.
PubMed PMID:
29701993
; PubMed Central PMCID:
PMC6450696
select
Melamed JR, Riley RS, Valcourt DM, Billingsley MM, Kreuzberger NL, Day ES.
Quantification of siRNA Duplexes Bound to Gold Nanoparticle Surfaces.
Methods Mol Biol
2017;
1570
:1-15
doi: 10.1007/978-1-4939-6840-4_1.
PubMed PMID:
28238126
; PubMed Central PMCID:
PMC5555579
select
Methods in Molecular Biology

[Internet]
New York, NY: Springer New York;
2017.
-p.
Available from: http://link.springer.com/10.1007/978-1-4939-6840-4.
select
Melamed J, Riley R, Valcourt D, Billingsley M, Kreuzberger N, Day E.
Quantification of siRNA Duplexes Bound to Gold Nanoparticle Surfaces.
In:
Methods in Molecular Biology

[Internet]
New York, NY: Springer New York;
2017.
Chapter Chapter 1;
1-15p.
Available from: http://link.springer.com/10.1007/978-1-4939-6840-4_1.
What would you like to do?
Append to existing collection
Create a new collection
Collection name:
Choose a collection: